Related Experiment Video

Updated: Aug 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

[Regulation of soluble TRAIL and membrane TRAIL in Jurkat cells by PMA]

Yan Li1, Yun-xin Cao, Yun Zhang

  • 1Department of Immunology, Fourth Military Medical University, Xi'an 710032, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|May 3, 2005
PubMed
Abstract

Insights

Phorbol myristic acetate (PMA) upregulates both soluble and membrane-bound TNF-related apoptosis-inducing ligand (TRAIL) in Jurkat cells. Both forms of TRAIL demonstrate cytotoxic activity against target cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Context:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) plays a crucial role in apoptosis.
  • TRAIL exists in both soluble (sTRAIL) and membrane-bound (mTRAIL) forms.
  • Understanding TRAIL regulation is key to developing targeted cancer therapies.

Purpose:

  • To investigate the effect of phorbol myristic acetate (PMA) on the expression of sTRAIL and mTRAIL in Jurkat cells.
  • To determine the cytotoxic potential of both sTRAIL and mTRAIL.
  • To elucidate the role of protein kinase C (PKC) activation in TRAIL regulation.

Summary:

  • PMA stimulation significantly upregulates both sTRAIL and mTRAIL expression in Jurkat cells.
  • sTRAIL levels peaked at 48 hours, while mTRAIL expression peaked at 60 hours post-PMA treatment.
  • Both sTRAIL and mTRAIL exhibited significant cytotoxic activity against DR4/DR5-expressing Raji cells.

Impact:

  • This study highlights PMA's role in enhancing TRAIL-mediated apoptosis.
  • Findings suggest that modulating TRAIL expression via PKC activation could be a therapeutic strategy.
  • Provides insights into the differential kinetics of sTRAIL and mTRAIL induction.

More Related Videos

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...